Authored by Tom Ozimek via The Epoch Times (emphasis ours)
Great News: U.S. Drug Overdose Deaths Plummet in 2024
According to the latest provisional data released by the Centers for Disease Control and Prevention (CDC) on May 14, drug overdose deaths in the United States saw a significant decline in 2024, dropping to the lowest level since before the pandemic hit.
The report indicates that 80,391 individuals lost their lives to drug overdoses in 2024, reflecting a remarkable 26.9 percent decrease from the previous year’s figure of 110,037. This decline represents the most substantial one-year drop in drug overdose deaths since the CDC began collecting comparable data over 40 years ago.
This positive trend marks the second consecutive year of decline following a surge in overdose deaths during and post the COVID-19 pandemic. Factors such as social isolation, disruptions in treatment access, and other variables had contributed to the peak of nearly 115,000 overdose deaths in 2023.
With all states except Nevada and South Dakota reporting declines in drug-related fatalities, regions like West Virginia witnessed a notable 43.5 percent decrease. While the final statistics may undergo slight changes as data is finalized, the CDC’s data unmistakably points to a downward trajectory.
The reduction primarily stems from a drop in fentanyl-related deaths. In 2023, the synthetic opioid, known to be over 50 times more potent than heroin, was associated with over 76,000 fatalities. However, this number decreased to slightly over 48,000 in 2024.
Experts attribute several factors to this decline, including increased availability of the overdose reversal drug naloxone (Narcan), which became accessible over the counter in 2023 and is now carried by most first responders. Additionally, enhanced utilization of addiction treatment medications and shifts in drug distribution patterns may have played a role.
Despite this positive development, the latest data highlighted concerning rises in deaths linked to stimulants like methamphetamine and cocaine.
Deaths involving meth surged from 29,456 to 37,096, while cocaine-related fatalities witnessed an increase of approximately 8,000, reaching 30,833. Given that many overdose cases involve multiple substances, it remains unclear how many of these deaths were solely due to stimulants.
The Trump administration has escalated efforts to disrupt the international supply chain responsible for inundating the nation with synthetic opioids.
While most fentanyl consumed in the U.S. is manufactured in Mexico, the raw materials used predominantly originate from China. A Pulitzer Prize-winning investigation by Reuters last year uncovered how Chinese chemical suppliers and Mexican cartels continue to perpetuate the epidemic.
Reporters were able to legally acquire all the necessary chemicals and equipment to produce $3 million worth of fentanyl for a mere $3,600, exploiting a now-closed customs loophole known as the “de minimis” rule. This exemption had allowed duty-free import of goods valued at or under $800.
A recent report from the House Select Committee on the Chinese Communist Party (CCP) revealed that Beijing not only fails to curb the export of fentanyl precursors but actively encourages it.
According to the report, the Chinese government provides tax rebates and state subsidies to companies producing illegal synthetic opioid components, fueling what lawmakers denounce as a deliberate attack on the U.S.
“The Chinese Communist Party’s actions, as detailed in our report, indicate a desire for increased fentanyl flow into our country,” remarked Select Committee Chair Mike Gallagher (R-Wis.) during an April 16, 2024, hearing. “It welcomes the chaos and devastation resulting from this epidemic, leading to more American fatalities.”
In response, the Trump administration announced in February imposition of new targeted tariffs on China’s synthetic drug supply chain, aiming to disrupt fentanyl precursor production and export.
Loading…